Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

NCT01596413 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The company currently does not have plans to conduct this study

Conditions

Chemotherapy Induced Nausea and Vomiting

Interventions

DRUG: Sancuso
DRUG: IV granisetron

Sponsor

Kyowa Kirin Pharmaceutical Development Ltd